Rectal Neoplasm
13
3
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
1 terminated out of 13 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (13)
Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome
Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care
Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Previously Irradiated Patients, an Italian Association for Radiotherapy and Clinical Oncology (AIRO)-GI Platform: a Multi-centre Prospective Observational Study
Loop Ileostomy Closure:Stapled or Hand-sewn Anastomoses? Suture or Mesh Closure of the Stoma Site?
Prospective Multicenter Randomized Controlled Trial On Two-Stage Turnbull-Cutait Coloanal Anastomosis For Rectal
Intraoperative Radiotherapy for Rectal Cancer Using the Photon Radiosurgery System
Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer
Multicentric Study an Endoscopic Treatment of Digestive Neoplasia by Submucosal Dissection Evaluation of a New Water Jet System
Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer
Efficacy Study of Robotic Surgery for Rectal Cancer
Preoperative Chemoradiotheray for Rectal Cancer
Randomized Comparison of Curved Cutter Stapler and Linear Stapler
Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer